Ondansetron Injection USP

SteriMax is pleased to announce the launch of Ondansetron 8 mg / 4 mL (2 mg / mL). To learn more visit the Ondansetron product page.

Ondansetron Injection USP

SteriMax is pleased to announce the launch of Ondansetron 4 mg/ 2 mL (2 mg / mL). To learn more visit the Ondansetron product page.

Busulfan for Injection

SteriMax is pleased to announce the launch of Busulfan. To learn more visit the Busulfan product page.

SteriMax New Product Acquisition

SteriMax is pleased to announce the acquisition of the following products from Valeant Canada effective December 1st, 2017.

Furosemide for Injection

SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page.

Bupivacaine Injection BP

SteriMax is pleased to announce the launch of Bupivacaine Injection BP. To learn more visit the Bupivacaine product page.

Diclofenac 1.5% w/w

SteriMax is pleased to announce the launch of Diclofenac 1.5% w/w. To learn more visit the Diclofenac product page.

Piperacillin and Tazobactam for Injection 40.5 g

SteriMax is pleased to announce the launch of Piperacillin and Tazobactam for Injection 40.5 g. To learn more visit the Piperacillin and Tazobactam for Injection product page.

cefTAZidime Launches

SteriMax is pleased to announce the launch of cefTAZidime for Injection BP in 1 g, 2 g, 3 g, and 6 g strengths. To learn more visit the cefTAZidime for Injection product page.

Phenytoin Launches

SteriMax is pleased to announce the launch of Phenytoin for Injection in 2 mL and 5 mL strengths. To learn more visit the Phenytoin product page.